Market revenue in 2021 | USD 33.2 million |
Market revenue in 2030 | USD 259.9 million |
Growth rate | 25.7% (CAGR from 2021 to 2030) |
Largest segment | Oncology |
Fastest growing segment | CVD |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases |
Key market players worldwide | The Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai-based clinical trials solution provider market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 23.19% in 2021. Horizon Databook has segmented the Brazil ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
Bureaucracy is the greatest hurdle in Brazil. However, improvement in guidelines by the Brazilian government is anticipated to change the scenario in the coming years. The development of technologically advanced solutions that would help in better clinical research is at nascent phase in the country.
However, with increasing penetration of international players in the market, along with rising awareness regarding the use of these solutions for simplifying the overall clinical trial process from recruitment to data analysis, is anticipated to boost the market growth during the forecast period.
In addition, rising funding opportunities and increasing start-ups in the country are expected to change the market scenario. For instance, Stefanini Group, a Brazilian company, provides platforms for optimization and management of digital clinical trials. Such initiatives are anticipated to boost the market in the country in the coming years.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil ai-based clinical trials solution provider market, including forecasts for subscribers. This country databook contains high-level insights into Brazil ai-based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account